Lara E. Davis
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Molecular Biology top 10%
- Cancer Research top 5%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Jeremy WhelanMary E. KleinAndrew KoffMarta KovatchevaWilliam D. TapChristopher W. RyanYoufei GuanMatthew D. Breyer
- Topics
- Sarcoma Diagnosis and Treatment (36 papers)Lymphoma Diagnosis and Treatment (9 papers)Protein Degradation and Inhibitors (8 papers)
- Journals
- New England Journal of MedicineJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Lara E. Davis
91 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 873
- Molecular Biology 738
- Cancer Research 329
- Pathology and Forensic Medicine 241
Countries citing papers authored by Lara E. Davis
This map shows the geographic impact of Lara E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara E. Davis more than expected).
Fields of papers citing papers by Lara E. Davis
This network shows the impact of papers produced by Lara E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara E. Davis. The network helps show where Lara E. Davis may publish in the future.
Co-authorship network of co-authors of Lara E. Davis
This figure shows the co-authorship network connecting the top 25 collaborators of Lara E. Davis. A scholar is included among the top collaborators of Lara E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara E. Davis. Lara E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 13 | |
| 4 | 9 | |
| 5 | 1 | |
| 6 | 18 | |
| 7 | 1 | |
| 8 | 40 | |
| 9 | 3 | |
| 10 | 10 | |
| 11 | 174 | |
| 12 | 26 | |
| 13 | An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101breakdown → | 302 |
| 14 | 3 | |
| 15 | 114 | |
| 16 | 122 | |
| 17 | 20 | |
| 18 | 12 | |
| 19 | An approach for the study of drug distribution across ruminai epithelium in vivo. | 1 |
| 20 | Computer-Aided Design of 3-Port Waveguide Circulators. | 5 |
About Lara E. Davis
Lara E. Davis is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine, having authored 95 papers that have together received 2.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (36 papers), Lymphoma Diagnosis and Treatment (9 papers) and Protein Degradation and Inhibitors (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Oncology (873 citations) and Cancer Research (329 citations). Lara E. Davis has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jeremy Whelan, Mary E. Klein, Andrew Koff, Marta Kovatcheva, William D. Tap, Christopher W. Ryan, Youfei Guan, Matthew D. Breyer, Don McNaughton and Larissa Hammer. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.